• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病的区域热点:国际肾脏病学会-海湾肾脏健康协会的一项多国研究

Regional hotspots for chronic kidney disease: A multinational study from the ISN-GKHA.

作者信息

Garcia Pablo, Strasma Anna K, Wijewickrama Eranga, Arruebo Silvia, Caskey Fergus J, Damster Sandrine, Donner Jo-Ann, Jha Vivekanand, Levin Adeera, Nangaku Masaomi, Saad Syed, Tonelli Marcello, Ye Feng, Okpechi Ikechi G, Bello Aminu K, Johnson David W, Anand Shuchi

机构信息

Division of Nephrology, Department of Medicine, The University of New Mexico School of Medicine, Albuquerque, New Mexico, United States of America.

Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.

出版信息

PLOS Glob Public Health. 2024 Dec 5;4(12):e0004014. doi: 10.1371/journal.pgph.0004014. eCollection 2024.

DOI:10.1371/journal.pgph.0004014
PMID:39636884
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11620454/
Abstract

Chronic kidney disease (CKD) disproportionately affects certain populations as demonstrated by well-established subnational geographic hotspots of CKD in Central America and South Asia. Using data from the third iteration of the International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA), we aimed to systematically identify sub-national geographic or population clusters with high prevalence of CKD. The ISN-GKHA survey was conducted from July to September 2022, and included questions regarding whether a regional CKD hotspot existed in the respondents' country and possible contributors. A CKD hotspot was defined as a population cluster with a high risk of kidney failure requiring dialysis or transplant, or people dying from kidney failure. Overall, 46 out of 162 responding countries reported subnational hotspots for CKD within their country. Hotspots were reported across all regions, except for the Middle East. Latin America had the highest percentage (12 of 21, 57%) of countries reporting a regional CKD hotspot followed by the regions of North and East Asia, and Western Europe. Adults aged 18 to 44 years and rural populations were most commonly identified as the primary groups affected. Clinical factors were most commonly identified as contributors to CKD (hypertension in 74% and diabetes in 72%), followed by cultural (e.g., diet and herbal medications in 67%), and environmental (e.g., polluted water in 43%) factors. Latin American countries more commonly reported climate, cultural, and environmental factors as contributors compared to other regions. Across the world, there are a number of subnational regions where in-country experts identify a disproportionately higher burden of CKD, commonly occurring among younger age groups with clinical, cultural, and environmental contributors specific to these geographic regions. In-depth studies, starting with systematic epidemiology efforts, are needed to investigate the aetiopathogenesis of these CKD hotspots around the world so that tailored interventions can be offered.

摘要

慢性肾脏病(CKD)对某些人群的影响尤为严重,中美洲和南亚已确定的国家以下层面的CKD地理热点地区就证明了这一点。利用国际肾脏病学会全球肾脏健康地图集(ISN-GKHA)第三次迭代的数据,我们旨在系统地识别CKD高患病率的国家以下层面的地理或人群集群。ISN-GKHA调查于2022年7月至9月进行,包括关于受访者所在国家是否存在地区性CKD热点地区以及可能的影响因素的问题。CKD热点地区被定义为肾衰竭风险高、需要透析或移植的人群集群,或死于肾衰竭的人群。总体而言,162个回复国家中有46个报告了其国内存在国家以下层面的CKD热点地区。除中东地区外,所有地区均报告了热点地区。拉丁美洲报告有地区性CKD热点地区的国家比例最高(21个国家中的12个,占57%),其次是东亚和北亚地区以及西欧。18至44岁的成年人和农村人口最常被确定为受影响的主要群体。临床因素最常被确定为CKD的影响因素(高血压占74%,糖尿病占72%),其次是文化因素(如饮食和草药占67%)和环境因素(如受污染的水占43%)。与其他地区相比,拉丁美洲国家更常报告气候、文化和环境因素为影响因素。在全球范围内,有许多国家以下层面的地区,国内专家认为这些地区的CKD负担过高,且通常发生在较年轻的年龄组中,这些地区有特定的临床、文化和环境影响因素。需要从系统的流行病学研究开始进行深入研究,以调查世界各地这些CKD热点地区的病因发病机制,从而提供针对性的干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/671b/11620454/e21eb69b7eaf/pgph.0004014.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/671b/11620454/8c79c8c700c5/pgph.0004014.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/671b/11620454/c0ef781ea72e/pgph.0004014.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/671b/11620454/e21eb69b7eaf/pgph.0004014.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/671b/11620454/8c79c8c700c5/pgph.0004014.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/671b/11620454/c0ef781ea72e/pgph.0004014.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/671b/11620454/e21eb69b7eaf/pgph.0004014.g003.jpg

相似文献

1
Regional hotspots for chronic kidney disease: A multinational study from the ISN-GKHA.慢性肾脏病的区域热点:国际肾脏病学会-海湾肾脏健康协会的一项多国研究
PLOS Glob Public Health. 2024 Dec 5;4(12):e0004014. doi: 10.1371/journal.pgph.0004014. eCollection 2024.
2
Capacity for the management of kidney failure in the International Society of Nephrology South Asia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).国际肾脏病学会南亚地区肾衰竭管理能力:来自2023年国际肾脏病学会全球肾脏健康地图(ISN-GKHA)的报告
Kidney Int Suppl (2011). 2024 Apr;13(1):123-135. doi: 10.1016/j.kisu.2024.01.007. Epub 2024 Apr 8.
3
Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).国际肾脏病学会大洋洲及东南亚(OSEA)地区的肾衰竭管理能力:来自2023年国际肾脏病学会全球肾脏健康地图(ISN-GKHA)的报告。
Kidney Int Suppl (2011). 2024 Apr;13(1):110-122. doi: 10.1016/j.kisu.2024.01.004. Epub 2024 Apr 8.
4
Global variations in funding and use of hemodialysis accesses: an international report using the ISN Global Kidney Health Atlas.全球范围内血液透析通路的资金投入和使用情况的差异:基于 ISN 全球肾脏健康地图的国际报告。
BMC Nephrol. 2024 May 8;25(1):159. doi: 10.1186/s12882-024-03593-z.
5
Capacity for the management of kidney failure in the International Society of Nephrology North and East Asia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).国际肾脏病学会北亚和东亚地区肾衰竭管理能力:来自2023年国际肾脏病学会全球肾脏健康地图(ISN-GKHA)的报告。
Kidney Int Suppl (2011). 2024 Apr;13(1):97-109. doi: 10.1016/j.kisu.2024.02.001. Epub 2024 Apr 8.
6
An update on the global disparities in kidney disease burden and care across world countries and regions.全球各国和地区肾脏疾病负担和护理的全球差异更新。
Lancet Glob Health. 2024 Mar;12(3):e382-e395. doi: 10.1016/S2214-109X(23)00570-3.
7
Capacity for the management of kidney failure in the International Society of Nephrology Latin America region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).国际肾脏病学会拉丁美洲地区的肾衰竭管理能力:来自2023年国际肾脏病学会全球肾脏健康地图集(ISN-GKHA)的报告。
Kidney Int Suppl (2011). 2024 Apr;13(1):43-56. doi: 10.1016/j.kisu.2024.01.001. Epub 2024 Apr 8.
8
A global snapshot on health systems capacity for detection, monitoring, and management of acute kidney injury: A multinational study from the ISN-GKHA.全球卫生系统对急性肾损伤的检测、监测及管理能力的现状:一项来自国际肾脏病学会-全球肾脏健康行动(ISN-GKHA)的多国研究
PLOS Glob Public Health. 2024 Oct 15;4(10):e0003823. doi: 10.1371/journal.pgph.0003823. eCollection 2024.
9
Capacity for the management of kidney failure in the International Society of Nephrology Middle East region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).国际肾脏病学会中东地区肾衰竭管理能力:来自2023年国际肾脏病学会全球肾脏健康地图集(ISN-GKHA)的报告。
Kidney Int Suppl (2011). 2024 Apr;13(1):57-70. doi: 10.1016/j.kisu.2024.01.009. Epub 2024 Apr 8.
10
The 2023 Latin America report of the Countdown on health and climate change: the imperative for health-centred climate-resilient development.《2023年健康与气候变化倒计时拉丁美洲报告:以健康为中心的气候适应型发展的必要性》
Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May.

引用本文的文献

1
How a mysterious epidemic of kidney disease is killing thousands of young men.一种神秘的肾病疫情是如何致使数千名年轻男子死亡的。
Nature. 2025 Jun;642(8066):22-25. doi: 10.1038/d41586-025-01689-6.

本文引用的文献

1
An update on the global disparities in kidney disease burden and care across world countries and regions.全球各国和地区肾脏疾病负担和护理的全球差异更新。
Lancet Glob Health. 2024 Mar;12(3):e382-e395. doi: 10.1016/S2214-109X(23)00570-3.
2
Kidney disease characteristics, prevalence, and risk factors in León, Nicaragua: a population-based study.尼加拉瓜莱昂市的肾脏疾病特征、患病率和危险因素:一项基于人群的研究。
BMC Nephrol. 2023 Nov 12;24(1):335. doi: 10.1186/s12882-023-03381-1.
3
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
全球、地区和国家 1990 年至 2021 年糖尿病负担,以及对 2050 年患病率的预测:2021 年全球疾病负担研究的系统分析。
Lancet. 2023 Jul 15;402(10397):203-234. doi: 10.1016/S0140-6736(23)01301-6. Epub 2023 Jun 22.
4
Inaxaplin for Proteinuric Kidney Disease in Persons with Two Variants.Inaxaplin 用于伴有两种变异的蛋白尿性肾病患者。
N Engl J Med. 2023 Mar 16;388(11):969-979. doi: 10.1056/NEJMoa2202396.
5
Hemoglobin Levels Among Male Agricultural Workers: Analyses From the Demographic and Health Surveys to Investigate a Marker for Chronic Kidney Disease of Uncertain Etiology.男性农业工人的血红蛋白水平:来自人口与健康调查的分析,以研究一种病因不明的慢性肾脏病的标志物。
J Occup Environ Med. 2022 Dec 1;64(12):e805-e810. doi: 10.1097/JOM.0000000000002703.
6
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
7
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
8
Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey.全球各国和地区终末期肾病护理状况:国际横断面调查。
BMJ. 2019 Oct 31;367:l5873. doi: 10.1136/bmj.l5873.
9
A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases.一个用于宣传和沟通的数字——全球超过8.5亿人患有肾脏疾病。
Kidney Int. 2019 Nov;96(5):1048-1050. doi: 10.1016/j.kint.2019.07.012. Epub 2019 Sep 30.
10
Chronic Kidney Disease of Unknown Cause in Agricultural Communities.农业社区中病因不明的慢性肾脏病
N Engl J Med. 2019 May 9;380(19):1843-1852. doi: 10.1056/NEJMra1813869.